Menu Back to Clinical-Trial-Disclosure-and-Data-Transparency-Conference

Overview

Short Courses: September 18
Conference: September 19-20


Clinical trial information transparency is taking on new dimensions. Clinical trial sponsors and academia are facing a host of new registration requirements in the US, EU, and elsewhere. With evolving requirements comes new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This conference will provide critical and timely information relating to global clinical trial disclosure and data transparency from those on the front lines.

NEW! This year's conference will have an even greater global presence than ever!


Check out our 2019 Program!


On-Demand Webinar

EU Device Regulations – The European Database on Medical Devices (Eudamed)
The EU’s 2017 passage of new medical device regulations presents substantial changes in how clinical trials of medical devices are disclosed in the EU, from protocol approval to the reporting of summary results. In 2020, Eudamed will provide the public with a comprehensive view of medical device research and approvals throughout the EU. This webinar will look at the new EU requirements and discuss how sponsors can approach meeting them.
Register today!

Who should attend?

Professionals involved in:
  • Compliance/Legal
  • Clinical trial disclosure
  • Transparency policies and compliance
  • Clinical operations
  • Medical writing, medical affairs, and medical communications
  • Regulatory
  • Publications
  • Biometrics
  • Data management
  • Disclosure
  • Data transparency/data sharing
  • Academia
  • Clinical/Medical Research
  • Patient Advocacy

Learning objectives

At the conclusion of this workshop, participants should be able to:
  • Discuss best practices to achieve good compliance
  • Assess the operational challenges and considerations in executing Innovative Trial Designs
  • Describe the changes in EudraCT and the practical implications
  • Describe the current status of Clinical Data Summary Pilot Program and any findings related to the program implementation to date

Program Committee

  • Robert  Paarlberg, MS, MSc
    Robert Paarlberg, MS, MSc Principal
    Paarlberg & Associates LLC, United States
  • Suzanne  Carlson, MA
    Suzanne Carlson, MA Consultant
    ABSD Associates, LLC, United States
  • Kelly  Coulbourne
    Kelly Coulbourne Associate Director, Clinical Trial Data Registries
    Allergan, United States
  • Patrick  Fawcett
    Patrick Fawcett Information Disclosure Administrator
    Office for ClinicalTrials.gov, University of Pittsburgh, United States
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Senior Trial Disclosure Director, Clinical Reporting Anchor & Disclosure
    Novo Nordisk A/S, Denmark
  • Francine  Lane, MBA
    Francine Lane, MBA Vice President, Global Transparency
    TrialScope, United States
  • Nate  Root, MSc
    Nate Root, MSc Associate Director, Disclosure and Transparency
    Ionis Pharmaceuticals, United States
Load More